StockWatch
·

Venmax Drugs And Pharmaceuticals Ltd

BSE: 531015

Shareholding Trends

Ownership split

PromoterPublicOthers
0%33%67%100%Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%0%0%0%Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingVENMAX
2026
26Sep

Board Meeting

The Company is submitting its Annual Report for the Financia…

BSE Filing
Board MeetingVENMAX
2026
7Sep

Board Meeting

The National Company Law Tribunal (NCLT) Hyderabad Bench has…

BSE Filing
Board MeetingVENMAX
2026
31Aug

Board Meeting

The Board of Directors will consider and approve the Notice …

BSE Filing
Board MeetingVENMAX
2026
29Jul

Board Meeting

The Board of Directors approved the allotment of 21,47,665 E…

BSE Filing
Board MeetingVENMAX
2026
7Feb

Board Meeting

Consider and approve the Unaudited Financial Results For The…

BSE Filing
Board MeetingVENMAX
2025
12Nov

Board Meeting

Consider and approve the un-audited financial results for th…

BSE Filing
Board MeetingVENMAX
2025
8Feb

Board Meeting

Un-audited Financial Results, Limited Review Report, Any oth…

BSE Filing
Board MeetingVENMAX
2024
11Nov

Board Meeting

Un-audited Financial Results, Limited Review Report, Any oth…

BSE Filing
Board MeetingVENMAX
2024
22Aug

Board Meeting

Consideration and approval of the Notice of the ensuing Thir…

BSE Filing
Board MeetingVENMAX
2024
14May

Board Meeting

consider and approve the Audited Standalone Financial Result…

BSE Filing